Back

GenCelix launches Korea-Japan regenerative medicine alliance

Verifying
  • GenCelix, DKMG and KOHJIN BIO signed an MOU launching the Korea-Japan Regenerative Medicine Alliance.
  • The agreement was signed Sept. 7 at Hilton Garden Inn Seoul Gangnam.
  • Joint projects must comply with applicable Korean and Japanese laws and regulatory approvals.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.